Voting Rights Announcements | 10 June 2010 06:51
WILEX AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)
10.06.2010 06:51
Dissemination of a Voting Rights announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
WILEX AG: Publication according to Section 26 paragraph 1 of the Securities
Trading Act (Stimmrechtsmitteilung nach § 26 Abs. 1 Wertpapierhandelsgesetz
- WpHG) for Europe-wide distribution:
WILEX AG, Grillparzerstr. 10, 81675 Munich, Germany (WKN 661472, ISIN
DE0006614720 respectively) has received on 09 June 2010 the following
voting rights announcement pursuant to Section 21 para. 1 of the Securities
Trading Act [Wertpapierhandelsgesetz; WpHG]:
1. UCB Pharma S.A., Brussels, Belgium informed us on 09 June 2010
according to Section 21 para. 1 of the Securities Trading Act, that
their voting interest in WILEX AG has exceeded the threshold of 15% and
amounted to 18.05% (2,880,069 voting rights) on 7 June 2010. Of these
2,880,069 voting rights (18.05%), 1,818,181 voting rights (11.39%) and
the underlying shares were directly held by UCB Pharma S.A. on 7 June
2010. The remaining 1,061,888 voting rights (6.65%) were attributed to
UCB Pharma S.A. pursuant to Section 22 para. 1 sentence 1 no. 5 of the
Securities Trading Act on such date.
From the following shareholder holding a voting interest of 3% or more in
WILEX AG voting rights were attributed to UCB Pharma S.A. on 7 June 2010:
- Apax Europe IV-A, L.P.
Furthermore UCB Pharma S.A. informed us voluntarily pursuant to Section 21
para. 1 of the Securities Trading Act, that on 9 June 2010 the voting
interest held by UCB Pharma S.A. in WILEX AG still exceeded the threshold
of 15% and amounted to 18.05% (2,880,069 voting rights). After the
completion of the acquisition of 1,061,888 shares (6.65%) in WILEX AG by
UCB Pharma S.A., all 2,880,069 voting rights (18.05%) and the underlying
shares were directly held by UCB Pharma S.A. on 9 June 2010.
2. UCB S.A., Brussels, Belgium, informed us on 09 June 2009 according to
Section 21 para. 1 of the Securities Trading Act, that their voting
interest in WILEX AG has exceeded the threshold of 15% and amounted to
18.05% (2,880,069 voting rights) on 7 June 2010. Of these 2,880,069
voting rights (18.05%), 1,818,181 voting rights (11.39%) were
attributed to UCB S.A. pursuant to Section 22 para. 1 sentence 1 no. 1
of the Securities Trading Act on 7 June 2010. The remaining 1,061,888
voting rights (6.65%) were attributed to UCB S.A. pursuant to Section
22 para. 1 sentence 1 no. 5 in conjunction with Section 22 para. 1
sentence 2 of the Securities Trading Act on such date.
From the following company controlled by UCB S.A. and holding a voting
interest of 3% or more in WILEX AG voting rights were attributed to UCB
S.A. on 7 June 2010:
- UCB Pharma S.A.
From the following shareholder holding a voting interest of 3% or more in
WILEX AG voting rights were attributed to UCB S.A. on 7 June 2010:
- Apax Europe IV-A, L.P.
Furthermore, UCB S.A. informed us voluntarily pursuant to Section 21 para.
1 of the Securities Trading Act, that on 9 June 2010, the voting interest
held by UCB S.A. in WILEX AG still exceeded the threshold of 15% and
amounted to 18.05% (2,880,069 voting rights). After the completion of the
acquisition of 1,061,888 shares (6.65%) in WILEX AG by UCB Pharma S.A., a
company controlled by UCB S.A., all 2,880,069 voting rights (18.05%) were
attributed to UCB S.A. pursuant to Section 22 para. 1 sentence 1 no. 1 of
the Securities Trading Act on 9 June 2010.
From the following company controlled by UCB S.A. and holding a voting
interest of 3% or more in WILEX AG voting rights were attributed to UCB
S.A. on 9 June 2010:
- UCB Pharma S.A.
3. Financière de Tubize S.A., Brussels, Belgium, informed us on 09 June
2009 according to Section 21 para. 1 of the Securities Trading Act, that
their voting interest in WILEX AG has exceeded the threshold of 15% and
amounted to 18.05% (2,880,069 voting rights) on 7 June 2010. Of these
2,880,069 voting rights (18.05%), 1,818,181 voting rights (11.39%) were
attributed to Financière de Tubize S.A. pursuant to Section 22 para. 1
sentence 1 no. 1 of the Securities Trading Act on 7 June 2010. The
remaining 1,061,888 voting rights (6.65%) were attributed to Financière de
Tubize S.A. pursuant to Section 22 para. 1 sentence 1 no. 5 in conjunction
with Section 22 para. 1 sentence 2 of the Securities Trading Act.
From the following companies each controlled by Financière de Tubize S.A.
and each holding a voting interest of 3% or more in WILEX AG voting rights
were attributed to Financière de Tubize S.A. on 7 June 2010:
- UCB Pharma S.A.;
- UCB S.A.
From the following shareholder holding a voting interest of 3% or more in
WILEX AG voting rights were attributed to Financière de Tubize S.A. on 7
June 2010:
- Apax Europe IV-A, L.P.
Furthermore Financière de Tubize S.A. informed us voluntarily pursuant to
Section 21 para. 1 of the Securities Trading Act, that on 9 June 2010, the
voting interest held by Financière de Tubize S.A. in WILEX AG still
exceeded the threshold of 15% and amounted to 18.05% (2,880,069 voting
rights). After the completion of the acquisition of 1,061,888 shares
(6.65%) in WILEX AG by UCB Pharma S.A., a company controlled by Financière
de Tubize S.A., all 2,880,069 voting rights (18.05%) were attributed to
Financière de Tubize S.A. pursuant to Section 22 para. 1 sentence 1 no. 1
of the Securities Trading Act on 9 June 2010.
From the following companies each controlled by Financière de Tubize S.A.
and each holding a voting interest of 3% or more in WILEX AG voting rights
were attributed to Financière de Tubize S.A. on 9 June 2010:
- UCB Pharma S.A.;
- UCB S.A.
Munich, 10 June 2010
WILEX AG
Executive Management Board
10.06.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Internet: www.wilex.com
End of News DGAP News-Service
---------------------------------------------------------------------------